Search

everythinglearnresearchcommunity

for

Search:↓

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Lifestyle changes and clomiphene are first-line treatments for infertility in women with PCOS, with other options available if these fail.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The case shows skin changes can indicate deeper health issues like insulin resistance, which are challenging to manage.

Three to five ovarian punctures are best for improving fertility in women with PCOS without harming the ovaries.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

Skin changes in women with PCOS are mainly due to hormonal imbalances.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

PCOS is a major cause of infertility in women of childbearing age.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

PCOS is a common condition in women that can lead to infertility and other health issues, and it's diagnosed by specific criteria with various treatment options available.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Spironolactone did not make hair thinner in women with excess hair growth.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Increased FGFR2b signaling, influenced by androgens, plays a role in causing acne.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

Testosterone therapy improved physical and social health in a male with 49,XXXXY syndrome.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.